Status:
UNKNOWN
Assessing Feasibility of Prolonged Repetitive Near Infrared Light Stimulation in Early to Mid-Stage Dementia
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Quietmind Foundation
Conditions:
Mild to Moderate Dementia
Eligibility:
All Genders
50-85 years
Phase:
NA
Brief Summary
This study will gather data to see if infrared and near infrared light frequency can increase the activity of brain cells and provide support for the cell's ability to repair and protect themselves ag...
Detailed Description
Research suggests that impaired regional cerebral blood flow (rCBF) \[flow of blood in certain parts of the brain\] plays an important role in dementia. Infrared and near infrared light frequency has ...
Eligibility Criteria
Inclusion
- Aged 50-85 years with an independently provided diagnosis of dementia, probable Alzheimer's type.
- Dementia symptoms not greater than early to mid-stage dementia
- Generally healthy as indicated by recent physical examination within the last 6 months
- If labs are available within the last 6 months, renal function, hepatic function, cardiac function should be normal
Exclusion
- Diagnosed actively growing intracranial pathology (tumors etc.)
- Misusing illegal substances or alcohol
- Previous history of stroke
- History of aggression or violence
- History of major psychiatric illness
- No underlying CNS pathology (confined to tumor, epilepsy only)
Key Trial Info
Start Date :
October 15 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03750409
Start Date
October 15 2018
End Date
October 15 2020
Last Update
August 19 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Quietmind Foundation
Elkins Park, Pennsylvania, United States, 19027
2
Baylor Scott and White Medical Center, Temple
Temple, Texas, United States, 76508